Home › Funds › WASATCH ADVISORS LP › RGEN
WASATCH ADVISORS LP position in RGEN
REPLIGEN CORP · Health Care
WASATCH ADVISORS LP reported holding 907,159 shares of RGEN (REPLIGEN CORP) in its Q3 2026 13F filing — a position valued at US$174.4M, representing 1.30% of its reported portfolio and ranking #18 among its reported holdings. WASATCH ADVISORS LP has disclosed RGEN holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-10-15 · Source: SEC EDGAR Form 13F-HR
How WASATCH ADVISORS LP's RGEN position evolved
WASATCH ADVISORS LP first disclosed a stake in RGEN in Q1 2026 at 1,243,531 shares (US$146.5M). The position peaked in Q2 2026 at 1,590,251 shares, worth US$217.0M. Across 3 filings, WASATCH ADVISORS LP increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 907,159 shares valued at US$174.4M — a reduction of -683,092 shares quarter over quarter.. Notable position changes include a 28% increase in Q2 2026 (shares rose 41% over the following quarter), a 43% trim in Q3 2026 (shares fell 7% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 1.24M | $146.51M | New |
| Q2 2026 | 1.59M | $216.97M | Add |
| Q3 2026 | 907.16K | $174.38M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About RGEN and 13F data
RGEN (REPLIGEN CORP) is a Health Care company. 32 other funds we track also report a position in RGEN — the largest reported positions include UNITED CAPITAL FINANCIAL ADVISORS, LLC (US$380.8M), Maverick Capital (US$270.8M), MAVERICK CAPITAL LTD (US$270.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding RGEN
- UNITED CAPITAL FINANCIAL ADVISORS, LLC 2.79M sh · $380.76M · Q2 2026
- Maverick Capital 1.98M sh · $270.77M · Q2 2026
- MAVERICK CAPITAL LTD 1.98M sh · $270.77M · Q2 2026
- CONGRESS ASSET MANAGEMENT CO 1.02M sh · $196.25M · Q3 2026
- RTW INVESTMENTS, LP 1.24M sh · $169.27M · Q2 2026
- Conestoga Capital Advisors, LLC 980.98K sh · $133.85M · Q2 2026
- Stephens Investment Management Group LLC 937.08K sh · $127.86M · Q2 2026
- FRED ALGER MANAGEMENT, LLC 733.74K sh · $100.11M · Q2 2026
- DeepCurrents Investment Group LLC 94.44M sh · $96.80M · Q2 2026
- GENEVA CAPITAL MANAGEMENT LLC 656.09K sh · $89.52M · Q2 2026
- Aequim Alternative Investments LP 75.00M sh · $77.09M · Q2 2026
More on WASATCH ADVISORS LP
FAQ
How long has WASATCH ADVISORS LP held RGEN?
WASATCH ADVISORS LP has disclosed RGEN holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is WASATCH ADVISORS LP's current position in RGEN?
As of Q3 2026, WASATCH ADVISORS LP holds 907.16K shares of RGEN (REPLIGEN CORP), valued at $174.38M, representing 1.30% of its reported portfolio and ranking #18.
Has WASATCH ADVISORS LP been buying or selling RGEN?
In the latest 13F filing (Q3 2026), WASATCH ADVISORS LP reduced its position in RGEN. The position peaked in Q2 2026 at 1.59M shares.
Which other funds hold RGEN?
Other major institutional holders of RGEN include UNITED CAPITAL FINANCIAL ADVISORS, LLC, Maverick Capital, MAVERICK CAPITAL LTD, among 32 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.